By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker this week said that it has amended the terms of a credit agreement with JPMorgan Chase Bank, under which the maturity date of its revolving line of credit has been extended to May 24, 2016, and the amount available under the credit facility has been expanded to $250 million. As of May 24, 2011, Bruker had outstanding borrowings under the facility of roughly $185.5 million, while the outstanding principal amount under the term loan facility totaled $105 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.